The Recall Desk
SevereFDA (Drugs)·D-0752-2026·Announced 2026-08-19

Apollo Care Recalls Semaglutide Vials Due to Particulate Matter

Apollo Care, LLC is recalling 4,748 vials of Semaglutide 0.9mg due to the presence of nylon and silk particulate matter.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, and the presence of particulate matter in a sterile injectable product poses a significant risk of injury or adverse health consequences.

Plain-English summary

Apollo Care, LLC is recalling 4,748 vials of Semaglutide 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vials. The recall was initiated because the product was found to contain particulate matter identified as nylon/polyamide and silk/proteinaceous-type material.

The affected product is Lot AC-017131 with an expiration date of 8/30/2026. The vials are prescription-only and intended for subcutaneous injection. The product was distributed nationwide within the U.S.

Consumers and healthcare providers should stop using the affected vials and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
SEMAGLUTIDE 0.9mg (0.9 mg/mL), 1 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-810-01
Manufacturer
Apollo Care, LLC
Category
Drug — Injectable
Hazard
Affected units
4,748

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot: AC-017131
  • Exp. 8/30/2026.

Distribution

Distributed nationwide across the United States.

Related recalls

Same manufacturer · Apollo Care, LLC

See all →

Same hazard · particulate matter

See all →